belimumab
| Form | Strength | ANAN | ASMP | LACH | LALK | LOHH | LOLR | LOWC | SDSD | SESE | SFSF | Formulary Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| POWDER FOR INJECTION, INTRAVENOUS | 120 mg, 400 mg | Restricted to use in the outpatient setting by Rheumatology only | ||||||||||
| SOLUTION, SUBCUTANEOUS | 200 mg/mL | non formulary |